Evidence for an FMR1 mRNA Gain-Of-Function Toxicity Mechanism in the Pathogenesis of Fragile-X Associated Premature Ovarian Insufficiency
Roseanne Rosario(MRC Centre for Reproductive Health), Richard A. Anderson(MRC Centre for Reproductive Health)
Cited by 0
Related Papers
Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis
|BMC Developmental Biology|2007|238
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
|Human Reproduction Update|2023|117
Germ Cell Proliferation and Apoptosis in the Developing Human Ovary
|The Journal of Clinical Endocrinology & Metabolism|2005|92
Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex <i>in vitro</i>
|Human Reproduction|2023|33
RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
|Molecular Human Reproduction|2017|31